Effect of midkine on gemcitabine resistance in biliary tract cancer

Gemcitabine-based chemotherapy is one of the most effective and commonly used chemotherapeutic regimens for biliary tract cancer (BTC). However, development of resistance to this drug limits its efficacy. The present study aimed to explore the effects of midkine (MDK) on the resistance of BTC cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yongliang, Yan, Bing, Guo, Huihui, Qiu, Li, Sun, Xinrong, Wang, Xiang, Shi, Qian, Bao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810218/
https://www.ncbi.nlm.nih.gov/pubmed/29344648
http://dx.doi.org/10.3892/ijmm.2018.3399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810218/
https://www.ncbi.nlm.nih.gov/pubmed/29344648
http://dx.doi.org/10.3892/ijmm.2018.3399

Ejemplares similares